Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Both antiviral treatments and monoclonal antibodies that treat Covid-19 are available across the city, but some public health experts worry that too few people know how to get them.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Pills and suppositories that promise to balance the vaginal microbiome are lining drugstore shelves and online marketplaces. But are they backed by science?
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Three critical questions to secure F.D.A. integrity.
Readers reflect on Donald Trump as both a party boss and a sore loser. Also: Reforming the patent system.
We answer a common reader question about the opioid crisis and legalizing drugs.
And information about antivirals, from Times reporters and readers.